Journal of Ovarian Research

Papers
(The median citation count of Journal of Ovarian Research is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-12-01 to 2024-12-01.)
ArticleCitations
The role of oxidative stress in ovarian aging: a review95
Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment84
The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis44
An overview of FSH-FSHR biology and explaining the existing conundrums42
Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses41
Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer41
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells38
Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis38
Targeting purine metabolism in ovarian cancer37
Curcumin inhibits ovarian cancer progression by regulating circ-PLEKHM3/miR-320a/SMG1 axis37
Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized37
Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells37
MiR-200b is upregulated in plasma-derived exosomes and functions as an oncogene by promoting macrophage M2 polarization in ovarian cancer36
Melatonin enhances SIRT1 to ameliorate mitochondrial membrane damage by activating PDK1/Akt in granulosa cells of PCOS36
Mechanisms of ovarian aging in women: a review35
Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging33
MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A33
Quercetin alleviates cyclophosphamide-induced premature ovarian insufficiency in mice by reducing mitochondrial oxidative stress and pyroptosis in granulosa cells31
Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer31
The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal‐weight population30
Efficacy of PD-1/PD-L1 inhibitors in ovarian cancer: a single-arm meta-analysis30
RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis27
Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients27
Association between morphologic grading and implantation rate of Euploid blastocyst25
Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status24
Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR24
Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression23
Choosing the right timing for interval debulking surgery and perioperative chemotherapy may improve the prognosis of advanced epithelial ovarian cancer: a retrospective study22
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer22
Effects of single and multiple transplantations of human umbilical cord mesenchymal stem cells on the recovery of ovarian function in the treatment of premature ovarian failure in mice22
Ameliorative effect of recombinant human lactoferrin on the premature ovarian failure in rats after cyclophosphamide treatments20
Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses20
Randomized double blind clinical trial evaluating the Ellagic acid effects on insulin resistance, oxidative stress and sex hormones levels in women with polycystic ovarian syndrome20
UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway20
RETRACTED ARTICLE: H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p/PCBP2 axis20
LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p19
Two-dimensional and three-dimensional T2 weighted imaging-based radiomic signatures for the preoperative discrimination of ovarian borderline tumors and malignant tumors19
Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosis19
The abnormal level of HSP70 is related to Treg/Th17 imbalance in PCOS patients19
LncRNA DLEU1 is overexpressed in premature ovarian failure and sponges miR-146b-5p to increase granulosa cell apoptosis19
Circ_0061140 knockdown inhibits tumorigenesis and improves PTX sensitivity by regulating miR-136/CBX2 axis in ovarian cancer18
Molecular and biological functions of gingerol as a natural effective therapeutic drug for cervical cancer18
LncRNA HOTAIRM1, miR-433-5p and PIK3CD function as a ceRNA network to exacerbate the development of PCOS18
Maintenance therapy for newly diagnosed epithelial ovarian cancer– a review18
A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer18
TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer17
Role of different non-coding RNAs as ovarian cancer biomarkers17
Sentinel lymph node identification in early stage ovarian cancer: is it still possible after prior tumor resection?17
Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway17
Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patients17
Propofol suppresses cell viability, cell cycle progression and motility and induces cell apoptosis of ovarian cancer cells through suppressing MEK/ERK signaling via targeting circVPS13C/miR-145 axis17
COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?17
CACNA1C is a prognostic predictor for patients with ovarian cancer17
Exosomes secreted by chemoresistant ovarian cancer cells promote angiogenesis16
Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer16
Age-related decline in the expression of GDF9 and BMP15 genes in follicle fluid and granulosa cells derived from poor ovarian responders16
Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism16
p38β - MAPK11 and its role in female cancers16
Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer16
Integrative analysis of key candidate genes and signaling pathways in ovarian cancer by bioinformatics15
Trends in incidence and mortality for ovarian cancer in China from 1990 to 2019 and its forecasted levels in 30 years15
TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells15
A risk model of gene signatures for predicting platinum response and survival in ovarian cancer15
Lipidomics analysis of human follicular fluid form normal-weight patients with polycystic ovary syndrome: a pilot study15
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer15
Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature15
Endogenous, tissue-resident stem/progenitor cells in gonads and bone marrow express FSHR and respond to FSH via FSHR-315
CT-based machine learning radiomics predicts CCR5 expression level and survival in ovarian cancer15
MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer15
The role of MMP-14 in ovarian cancer: a systematic review15
The boosting effects of melatonin on the expression of related genes to oocyte maturation and antioxidant pathways: a polycystic ovary syndrome- mouse model15
Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer15
Metabolic differences in women with premature ovarian insufficiency: a systematic review and meta-analysis14
Down-regulation of ZNF252P-AS1 alleviates ovarian cancer progression by binding miR-324-3p to downregulate LY6K14
A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer14
Lnc-GULP1–2:1 affects granulosa cell proliferation by regulating COL3A1 expression and localization14
Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq14
Aged mice ovaries harbor stem cells and germ cell nests but fail to form follicles14
Mutation analysis of the TUBB8 gene in primary infertile women with oocyte maturation arrest14
BDNF and TrKB expression levels in patients with endometriosis and their associations with dysmenorrhoea14
Pharmacological inhibition of the PI3K/PTEN/Akt and mTOR signalling pathways limits follicle activation induced by ovarian cryopreservation and in vitro culture13
Berberine inhibited metastasis through miR-145/MMP16 axis in vitro13
miR-145 inhibits mitochondrial function of ovarian cancer by targeting ARL5B13
Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network13
Health related quality of life and psychological parameters in different polycystic ovary syndrome phenotypes: a comparative cross-sectional study13
Age of ovarian cancer diagnosis among BRIP1, RAD51C, and RAD51D mutation carriers identified through multi-gene panel testing13
A poor prognostic metastatic nongestational choriocarcinoma of the ovary: a case report and the literature review13
Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer13
Comparison of dietary micronutrient intake in PCOS patients with and without metabolic syndrome13
Establishment and validation of an RNA binding protein-associated prognostic model for ovarian cancer12
Characterization of a novel mutation V136L in bone morphogenetic protein 15 identified in a woman affected by POI12
Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA12
Predictive factors of endometriosis progression into ovarian cancer12
miR-600 promotes ovarian cancer cells stemness, proliferation and metastasis via targeting KLF912
Ovarian microcystic stromal tumor with omental metastasis: the first case report and literature review12
Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study12
Association between atypical endometriosis and ovarian malignancies in the real world12
RETRACTED ARTICLE: LncRNA CTBP1-AS2 sponges miR-216a to upregulate PTEN and suppress endometrial cancer cell invasion and migration12
Minimal residual disease detection by multicolor flow cytometry in cryopreserved ovarian tissue from leukemia patients12
Amniotic fluid-derived exosomes attenuated fibrotic changes in POI rats through modulation of the TGF-β/Smads signaling pathway12
Identification of novel candidate biomarkers and immune infiltration in polycystic ovary syndrome11
The challenge of ovarian tissue culture: 2D versus 3D culture11
Estimating the risk of malignancy of adnexal masses: validation of the ADNEX model in the hands of nonexpert ultrasonographers in a gynaecological oncology centre in China11
Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present11
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report11
Construction autophagy-related prognostic risk signature to facilitate survival prediction, individual treatment and biomarker excavation of epithelial ovarian cancer patients11
Long non-coding RNA AFAP1-AS1 facilitates ovarian cancer progression by regulating the miR-107/PDK4 axis11
Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway11
MiR-425-5p accelerated the proliferation, migration, and invasion of ovarian cancer cells via targeting AFF411
Trophectoderm biopsy of blastocysts for a preimplantation genetic test does not affect serum β-hCG levels in early pregnancy: a study using propensity score matching11
LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis11
Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma11
Baicalin improves the functions of granulosa cells and the ovary in aged mice through the mTOR signaling pathway11
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy11
Comparison of the survival outcomes of laparoscopy versus laparotomy in treatment of early-stage ovarian cancer: a systematic review and meta-analysis11
Knockdown of circ-FURIN suppresses the proliferation and induces apoptosis of granular cells in polycystic ovary syndrome via miR-195-5p/BCL2 axis11
Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer11
LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer11
CircSETDB1 knockdown inhibits the malignant progression of serous ovarian cancer through miR-129-3p-dependent regulation of MAP3K310
Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progression10
A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance10
Effect of blastocyst morphology and developmental speed on transfer strategy for grade “C” blastocyst in vitrified‐warmed cycles10
Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer10
GIMAP7 induces oxidative stress and apoptosis of ovarian granulosa cells in polycystic ovary syndrome by inhibiting sonic hedgehog signalling pathway10
Abnormalities of early folliculogenesis and serum anti-Müllerian hormone in chinese patients with polycystic ovary syndrome10
Artificial oocyte activation may improve embryo quality in older patients with diminished ovarian reserve undergoing IVF-ICSI cycles10
Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors10
Identification and clinical significance of somatic oncogenic mutations in epithelial ovarian cancer10
Bisphenol A and bisphenol S both disrupt ovine granulosa cell steroidogenesis but through different molecular pathways10
Is polycystic ovary syndrome appropriately diagnosed by obstetricians and gynaecologists across China: a nationwide survey10
The presence of living endometrial cells in ovarian endometriotic cyst fluid may contribute to the recurrence of endometriosis after surgical excision of endometriomas10
LncRNA GAS5 is upregulated in polycystic ovary syndrome and regulates cell apoptosis and the expression of IL-610
Molecular response to PARP1 inhibition in ovarian cancer cells as determined by mass spectrometry based proteomics10
Clinical analysis and artificial intelligence survival prediction of serous ovarian cancer based on preoperative circulating leukocytes10
The LINC00922 aggravates ovarian cancer progression via sponging miR-361-3p10
Fertility care amidst the COVID19 pandemic: the American experience10
Exercise-induced irisin improves follicular dysfunction by inhibiting IRE1α-TXNIP/ROS-NLRP3 pathway in PCOS10
Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia10
LncRNA SNHG20 promotes migration and invasion of ovarian cancer via modulating the microRNA-148a/ROCK1 axis10
Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling10
Long non-coding RNA OIP5-AS1 suppresses microRNA-92a to augment proliferation and metastasis of ovarian cancer cells through upregulating ITGA69
Neoantigens and the tumor microenvironment play important roles in the prognosis of high-grade serous ovarian cancer9
Does Anti-Müllerian hormone vary during a menstrual cycle? A systematic review and meta-analysis9
FPR2 participates in epithelial ovarian cancer (EOC) progression through RhoA-mediated M2 macrophage polarization9
Plumbagin rescues the granulosa cell’s pyroptosis by reducing WTAP-mediated N6-methylation in polycystic ovary syndrome9
The survival outcome and complication of secondary cytoreductive surgery plus chemotherapy in recurrent ovarian cancer: a systematic review and meta-analysis9
Small RNA sequencing reveals distinct nuclear microRNAs in pig granulosa cells during ovarian follicle growth9
Successful live birth in a Chinese woman with P450 oxidoreductase deficiency through frozen-thawed embryo transfer: a case report with review of the literature9
Effect of 150 kHz electromagnetic radiation on the development of polycystic ovaries induced by estradiol Valerate in Sprague Dawley rats9
Ovarian inguinal hernia – a possibility in MURCS syndrome9
Hexokinase 2 promoted cell motility and proliferation by activating Akt1/p-Akt1 in human ovarian cancer cells9
A flexible short protocol in women with poor ovarian response over 40 years old9
Association between the food security status and dietary patterns with polycystic ovary syndrome (PCOS) in overweight and obese Iranian women: a case-control study9
A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer9
Ovarian reserve in nigerian women with sickle cell anaemia: a cross- sectional study9
Mechanistic and therapeutic insight into the effects of cinnamon in polycystic ovary syndrome: a systematic review9
Chronic exposure to perfluorohexane sulfonate leads to a reproduction deficit by suppressing hypothalamic kisspeptin expression in mice9
Female germline stem cells: aging and anti-aging9
ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in patients with ovarian cancer: a systematic review and meta-analysis9
Knockdown of heat shock protein family D member 1 (HSPD1) promotes proliferation and migration of ovarian cancer cells via disrupting the stability of mitochondrial 3-oxoacyl-ACP synthase (OXSM)9
Evaluation of mitochondria in mouse oocytes following cisplatin exposure9
Ovarian sex cord stromal tumours: analysis of the clinical and sonographic characteristics of different histopathologic subtypes9
Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors9
High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer9
Depression, sexual function and sexual quality of life in women with polycystic ovary syndrome (PCOS) and healthy subjects9
Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer9
Activation of SphK1 by adipocytes mediates epithelial ovarian cancer cell proliferation9
Plasma metabolomic characterization of premature ovarian insufficiency9
LncRNA DANCR counteracts premature ovarian insufficiency by regulating the senescence process of granulosa cells through stabilizing the interaction between p53 and hNRNPC9
The stromal microenvironment and ovarian aging: mechanisms and therapeutic opportunities9
Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis9
Potential effects of assisted reproductive technology on telomere length and telomerase activity in human oocytes and early embryos8
CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer8
Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) alleviate excessive autophagy of ovarian granular cells through VEGFA/PI3K/AKT/mTOR pathway in premature ovarian failure rat model8
Effects of n-3 PUFA supplementation on oocyte in vitro maturation in mice with polycystic ovary syndrome8
Effect of hysterectomy on ovarian function: a systematic review and meta-analysis8
Ovarian seromucinous tumors: clinicopathological features of 10 cases with a detailed review of the literature8
Comparison of anti-Müllerian hormone and antral follicle count in the prediction of ovarian response: a systematic review and meta-analysis8
Preparation of triangular silver nanoparticles and their biological effects in the treatment of ovarian cancer8
Ginseng alleviates folliculogenesis disorders via induction of cell proliferation and downregulation of apoptotic markers in nicotine-treated mice8
Incidence, dynamics and recurrences of reverse cleavage in aneuploid, mosaic and euploid blastocysts, and its relationship with embryo quality8
The value of serum progesterone level on day of human chorionic gonadotrophin administration / metaphase II oocyte ratio in predicting IVF/ICSI outcome in patients with normal ovarian reserve8
Construction and validation of a transcription factors-based prognostic signature for ovarian cancer8
Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer8
Genetic determination of the ovarian reserve: a literature review8
The impact of STAT3 and phospho-STAT3 expression on the prognosis and clinicopathology of ovarian cancer: a systematic review and meta-analysis8
Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice8
Polycystic ovary rat model exposure to 150 kHz intermediate frequency: hypothalamic-pituitary-ovarian axis at the receptor, cellular, tissue, and hormone levels8
Alterations of bacteriome, mycobiome and metabolome characteristics in PCOS patients with normal/overweight individuals8
Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma8
Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation8
miR-4324 inhibits ovarian cancer progression by targeting FEN18
MUC16 stimulates neutrophils to an inflammatory and immunosuppressive phenotype in ovarian cancer8
miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer8
Galectin-1 as a predictive biomarker in ovarian cancer8
Comparison of oocyte vitrification using a semi-automated or a manual closed system in human siblings: survival and transcriptomic analyses8
Laser-assisted hatching in lower grade cleavage stage embryos improves blastocyst formation: results from a retrospective study8
The effect of prophylactic bilateral salpingectomy on ovarian reserve in patients who underwent laparoscopic hysterectomy8
Effects and mechanisms of mUCMSCs on ovarian structure and function in naturally ageing C57 mice8
Diagnostic utility of a conventional MRI-based analysis and texture analysis for discriminating between ovarian thecoma-fibroma groups and ovarian granulosa cell tumors8
Short (seven days) versus standard (fourteen days) oestrogen administration in a programmed frozen embryo transfer cycle: a retrospective cohort study8
Past and present: a bibliometric study on polycystic ovary syndrome8
Potential factors result in diminished ovarian reserve: a comprehensive review8
The efficacy and safety of niraparib for ovarian cancer: a single-center observational study from China8
The impact of Pegylated liposomal doxorubicin in recurrent ovarian cancer: an updated meta-analysis of randomized clinical trials7
Curcumin: a natural organic component that plays a multi-faceted role in ovarian cancer7
Development and verification of a 7-lncRNA prognostic model based on tumor immunity for patients with ovarian cancer7
Characteristics of the vaginal microbiome in women with premature ovarian insufficiency7
Effects of electroacupuncture on the kisspeptin-gonadotropin-releasing hormone (GnRH) /luteinizing hormone (LH) neural circuit abnormalities and androgen receptor expression of kisspeptin/neurokinin B7
Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signaling7
The presence of ovarian endometrioma adversely affect ovarian reserve and response to stimulation but not oocyte quality or IVF/ICSI outcomes: a retrospective cohort study7
Expression of long noncoding RNAs in the ovarian granulosa cells of women with diminished ovarian reserve using high-throughput sequencing7
The molecular mechanism of circRHOBTB3 inhibits the proliferation and invasion of epithelial ovarian cancer by serving as the ceRNA of miR-23a-3p7
GATA1-induced upregulation of LINC01503 promotes carboplatin resistance in ovarian carcinoma by upregulating PD-L1 via sponging miR-766-5p7
A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview7
WISP1 induces ovarian cancer via the IGF1/αvβ3/Wnt axis7
Identification of key gene signatures for the overall survival of ovarian cancer7
LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancer7
LncRNA TMPO-AS1 suppresses the maturation of miR-335-5p to participate in polycystic ovary syndrome7
Ovarian fibrosarcoma: A single-institution experience and a review of the literature7
Effects of vitrified cryopreservation duration on IVF and neonatal outcomes7
Ovarian tissue cryopreservation in a patient with breast cancer during pregnancy: a case report7
Distinct expression and prognostic values of GATA transcription factor family in human ovarian cancer7
MR-based radiomics-clinical nomogram in epithelial ovarian tumor prognosis prediction: tumor body texture analysis across various acquisition protocols7
The causal association between systemic inflammatory regulators and primary ovarian insufficiency: a bidirectional mendelian randomization study7
Identification of TRPM2 as a prognostic factor correlated with immune infiltration in ovarian cancer7
Neuregulin-1 signaling regulates cytokines and chemokines expression and secretion in granulosa cell7
Low risk of OHSS with follitropin delta use in women with different polycystic ovary syndrome phenotypes: a retrospective case series7
A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer7
Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients7
CircCDK17 knockdown inhibits tumor progression and cell glycolysis by downregulaing YWHAZ expression through sponging miR-1294 in cervical cancer7
The effect of different vitrification protocols on cell survival in human ovarian tissue: a pilot study7
Simultaneous expression of steroid sulfatase and androgen receptor reduced overall survival of patients with epithelial ovarian tumors6
Chito-oligosaccharides and macrophages have synergistic effects on improving ovarian stem cells function by regulating inflammatory factors6
High visceral fat-to-muscle ratio is an independent factor that predicts worse overall survival in patients with primary epithelial ovarian, fallopian tube, and peritoneal cancer6
Early stage epithelial ovarian cancer metastasis through peritoneal fluid circulation6
Next-generation sequencing of 500 POI patients identified novel responsible monogenic and oligogenic variants6
High expression level of miR-1260 family in the peripheral blood of patients with ovarian carcinoma6
Predictive value of the number of frozen blastocysts in live birth rates of the transferred fresh embryos6
Anti-Müllerian hormone independently affect mtDNA copy number in human granulosa cells6
Oxidative stress and inflammatory markers in ovarian follicular fluid of women with diminished ovarian reserve during in vitro fertilization6
Characteristics and outcomes analysis of ovarian Sertoli–Leydig cell tumors (SLCTs): analysis of 15 patients6
In-vivo oogenesis of oogonial and mesenchymal stem cells seeded in transplanted ovarian extracellular matrix6
The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysis6
NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K/AKT/mTOR pathway in ovarian cancer6
Modulatory effects of R10 fraction of garlic (Allium sativum L.) on hormonal levels, T cell polarization, and fertility-related genes in mice model of polycystic ovarian syndrome6
A risk score system based on a six-microRNA signature predicts the overall survival of patients with ovarian cancer6
Effects of exogenous adiponectin supplementation in early pregnant PCOS mice on the metabolic syndrome of adult female offspring6
COVID-19 in Africa: an ovarian victory?6
Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers6
0.07720685005188